Skip to content
Logo text: ISPOR Improving healthcare decisions

Health Technology Assessment Central

The HTA Resource Center for Informing Healthcare Decisions

  • Home
  • What Is HTA?
  • HTA News and Events
  • Resource Library
  • Governance
  • Policy Interchange
  • Training and Development
« Back to ISPOR.org

News

Harmonizing HTA Methodological Standards Across EU Member States: Benefits and Challenges

January 9, 2019

https://globalforum.diaglobal.org/issue/january-2019/harmonizing-hta-methodological-standards-across-eu-member-states/

Posted in: Uncategorized

Post navigation

← ISPOR HTA Council Chair presents at the 1st China HTA Conference
Leading Global Experts Identify Good Practices in the Use of Evidence to Inform Decision Making for Health Technologies →

News

Growing Patient Involvement in Health Technology Assessment (HTA)
NICE launches online resource to help development and adoption of new health technologies
CADTH Celebrates Health Technology Assessment Leaders
Canada to create national drug agency to help cut cost of medicines
Bermuda Health Council Accepted Into RedETSA
Health Canada & HTA Body CADTH To Offer Parallel Scientific Advice
UHC Act: The role of Health Technology
Novartis first to benefit from NICE advice on ‘patient preference’
NICE collaborates with the Canadian Agency for Drugs and Technology in Health to offer parallel scientific advice
International HTA Agencies Collaborate On How To Determine Value-Based Prices

Twitter

Tweets about #HTA

#HTA

evers_silviaSilvia Evers@evers_silvia·
43m

@ErikKoffijberg of the @UTwente providing us great insights in the value of information analysis #voi as a way to handle #uncertainty in #healtheconomics during his keynote at the meeting of the Dutch Association of #HTA @NVTAG_nl

Reply on Twitter 1143870789734862848Retweet on Twitter 1143870789734862848Like on Twitter 11438707897348628481Twitter 1143870789734862848
VHC_CAPHRI_UMVHC_CAPHRI_UM@VHC_CAPHRI_UM·
50m

Key note speaker @ManuelaJoore giving great insights into handling #uncertainty in #HealthPolicy #decisionmaking during the meeting of the Dutch Association of #HTA @CAPHRI_UM @MaastrichtU

Reply on Twitter 1143868937064652800Retweet on Twitter 11438689370646528001Like on Twitter 11438689370646528002Twitter 1143868937064652800
SHTAC_uni_sotonSHTAC unisouthampton@SHTAC_uni_soton·
2h

We've just started working a new STA for NICE, Ustekinumab for treating moderately to severely active ulcerative colitis https://t.co/lzGODrBSmr #HTA #UlcerativeColitis #IBD

Reply on Twitter 1143858099649961985Retweet on Twitter 1143858099649961985Like on Twitter 1143858099649961985Twitter 1143858099649961985
Load More...
Privacy Policy | Disclaimer
Copyright © 2019 ISPOR – The Professional Society for Health Economics and Outcomes Research